Comparison of derivative spectrophotometric and liquid chromatographic methods for the determination of rofecoxib

Pharmazie

Volumn 59, Issue 6, 2004, Pages 453-456

  Erk, N ^a   Altuntas, T Gül ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ROFECOXIB;

ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; SPECTROPHOTOMETRY; ULTRAVIOLET SPECTROPHOTOMETRY;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE INHIBITORS; LACTONES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SULFONES;

EID: 3042531785     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Altuntas TG, Zanooz SS, Nebioglu D (1998) Quantitative determination of acrivastine and pseudoephedrine hydrochloride in pharmaceutical formulation by high performance liquid chromatography and derivative spectrophotometry. J Pharm Biomed Anal. 17: 103-109.
2. Altuntas TG, Korkmaz F, Nebioglu D (2000) Determination of tetrahydrozoline hydrochloride and fluorometholone in pharmaceutical formulations by HPLC and derivative UV spectrophotometry. Pharmazie. 55: 49-52.
3. Aravind MK, Prescilla R, Ofenstein JP (2002) A rapid and sensitive high performance liquid chromatography assay for rofecoxib in human serum. J Chromatogr Sci 40: 26-28.
4. Biryol I, Erk N (2003) Voltammetric, spectrophotometric and high performance liquid chromatographic analysis of olanzapine. Anal Lett (in press)
5. Chavez-Eng CM, Constanzer ML, Matuszewski BK (2000) Determination of rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection. J Chromatogr B Biomed Sci Appl 748: 31-39.
6. Chavez-Eng CM, Constanzer ML, Matuszewski BK (2002) High-performance liquid chromatographic-tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies. J Chromatogr B Analyt Technol Biomed Life Sci 767: 117-129.
7. Erk N (2002) Rapid spectrophotometric method for quantitative determination of simvastatin and fluvastatin in human serum and pharmaceutical formulation. Pharmazie 57: 817-819.
8. Fasanmade AA, Fell AF (1985) Determination of chlorpromazine and its sulphoxide in pharmaceutical dosage forms by third-order derivative ultraviolet spectroscopy. Analyst 110: 1117-1124.
9. Fell AF, Jarvie DR, Stewart MJ (1981) Analysis for paraquat by second-and fourth-derivative spectroscopy. Clin Chem 27: 286-292.
10. Jamali F, Sattari S (2000) High performance liquid chromatographic determination of cyclooxygenase II inhibitor rofecoxib in rat and human plasma. J Pharm Sci 3: 312-317.
11. Matthews CZ, Woolf EJ, Matuszewki BK (2002) Improved procedure for the determination of rofecoxib in human plasma involving 96-well solid-phase extraction and fluorescence detection. J Chromatogr A 949: 83-89.
12. Radhakrishan T, Sreenivas Rao D, Om Reddy G (2001) LC determination of rofecoxib in bulk and pharmaceutical formulations. J Pharm Biomed Anal 26: 617-628.
13. Vallano PT, Mazenko RS, Woolf EJ, Matuszewski BK (2002) Monolithic silica liquid chromatographphy columns for the determination of cyclooxgenase II inhibitors in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 779: 249-257.
14. Werner U, Werner D, Mundkowski R, Gillich M, Brune K (2001) Selective and rapid liquid chromatography-mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans. J Chromatogr B Biomed Sci Appl 760: 83-90.
15. Woolf E, Fu I, Matuszewski B (1999) Determination of rofecoxib, a cyclooxgenase-2 specific inhibitor, in human plasma using high performance liquid chromatography with post-column photochemical derivatization and fluorescence detection. J Chromatogr B Biomed Sci Appl 730: 221-227.